| SCHEDULE OF LONG-LIVED ASSETS BY GEOGRAPHIC AREAS |
Total
long-lived assets by country at June 27, 2026 and December 27, 2025 were:
SCHEDULE OF LONG-LIVED ASSETS BY GEOGRAPHIC AREAS
| Total Long-lived Assets | |
June 27, 2026 | | |
December 27, 2025 | |
| United States | |
$ | 8,465,769 | | |
$ | 4,105,034 | |
| Long lived assets | |
$ | 8,465,769 | | |
$ | 4,105,034 | |
|
| SCHEDULE SEGMENT INFORMATION BY REVENUE TYPE |
During
the three and six months ended June 27, 2026 and June 28, 2025, the Company derived its sales from the following geographies:
SCHEDULE SEGMENT INFORMATION BY REVENUE TYPE
| | |
Three Months Ended | | |
Three Months Ended | | |
Six Months Ended | | |
Six Months Ended | |
| | |
June 27, 2026 | | |
June 28, 2025 | | |
June 27, 2026 | | |
June 28, 2025 | |
| | |
Revenue | | |
% of Total | | |
Revenue | | |
% of Total | | |
Revenue | | |
% of Total | | |
Revenue | | |
% of Total | |
| United States | |
$ | 12,326,808 | | |
| 97 | % | |
$ | 8,183,644 | | |
| 97 | % | |
$ | 22,397,674 | | |
| 96 | % | |
$ | 18,235,596 | | |
| 96 | % |
| Other Americas | |
| — | | |
| — | | |
| 22,533 | | |
| — | | |
| 49,935 | | |
| — | | |
| 33,960 | | |
| — | |
| Total Americas | |
| 12,326,808 | | |
| 97 | | |
| 8,206,177 | | |
| 97 | | |
| 22,447,609 | | |
| 96 | | |
| 18,269,556 | | |
| 96 | |
| Asia – Pacific | |
| 55,998 | | |
| — | | |
| 118,656 | | |
| 1 | | |
| 126,968 | | |
| 1 | | |
| 376,510 | | |
| 2 | |
| Europe | |
| 351,628 | | |
| 3 | | |
| 130,050 | | |
| 2 | | |
| 711,227 | | |
| 3 | | |
| 347,309 | | |
| 2 | |
| Total Revenues | |
$ | 12,734,434 | | |
| 100 | % | |
$ | 8,454,883 | | |
| 100 | % | |
$ | 23,285,804 | | |
| 100 | % | |
$ | 18,993,375 | | |
| 100 | % |
|
| SCHEDULE OF SEGMENT REPORTING INFORMATION, BY SEGMENT |
During
the three and six months ended June 27, 2026 and June 28, 2025, the Company derived its sales from the following display applications:
SCHEDULE OF SEGMENT REPORTING INFORMATION, BY SEGMENT
| | |
Three Months
Ended | | |
Three Months
Ended | | |
Six Months
Ended | | |
Six Months
Ended | |
| | |
June 27, 2026 | | |
June 28, 2025 | | |
June 27, 2026 | | |
June 28, 2025 | |
| Defense | |
$ | 7,310,425 | | |
$ | 6,222,034 | | |
$ | 12,620,828 | | |
$ | 14,683,387 | |
| Industrial | |
| 20,400 | | |
| 1,030,977 | | |
| 67,718 | | |
| 1,422,665 | |
| Medical | |
| 309,343 | | |
| 213,380 | | |
| 326,182 | | |
| 572,300 | |
| Consumer and other product | |
| — | | |
| 32,045 | | |
| 50,160 | | |
| 49,969 | |
| Net product revenues | |
| 7,640,168 | | |
| 7,498,436 | | |
| 13,064,888 | | |
| 16,728,321 | |
| R&D | |
| 2,168,244 | | |
| 907,907 | | |
| 3,458,660 | | |
| 2,144,574 | |
| License and royalties | |
| 55,998 | | |
| 48,540 | | |
| 120,926 | | |
| 120,480 | |
| ASC 606 revenues | |
| 9,864,410 | | |
| 8,454,883 | | |
| 16,644,474 | | |
| 18,993,375 | |
| Grant | |
| 2,598,546 | | |
| — | | |
| 6,040,241 | | |
| — | |
| Collaboration | |
| 271,478 | | |
| — | | |
| 601,089 | | |
| — | |
| Non ASC 606 revenues | |
| 2,870,024 | | |
| — | | |
| 6,641,330 | | |
| — | |
| Total Revenues | |
$ | 12,734,434 | | |
$ | 8,454,883 | | |
$ | 23,285,804 | | |
$ | 18,993,375 | |
|